Recent progress in the repurposing of drugs/molecules for the management of COVID-19.

This article reviews the FDA approved drugs/molecules which could be repurposed in the combination or single to combat the COVID-19. EXPERT OPINION: In this focused review, we suggested the repurposing of the pathogen-centric, host-centric, dual sword (act as pathogen-centric as well as host-centric), and the combinatorial (pathogen and host-centric) drugs against COVID-19 patients. These drugs singly or in combination could be effective for the management of COVID-19. PMID: 33270490 [PubMed - as supplied by publisher]
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Tags: Expert Rev Anti Infect Ther Source Type: research